Videos de Experimentos Relacionados
Hepatitis E: un virus en la espera.
1Department of Medicine, University of California, San Francisco, USA.
Lancet (London, England)
|August 26, 1995
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate.
Molecular genetics and metabolism reports·2017
Same author
Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary.
Metabolic brain disease·2016
Same author
Refeeding syndrome in a young woman with argininosuccinate lyase deficiency.
Molecular genetics and metabolism reports·2016
Same author
Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.
Digestive diseases and sciences·2016
Same author
Glutamine and hyperammonemic crises in patients with urea cycle disorders.
Molecular genetics and metabolism·2015
Same author
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.
Molecular genetics and metabolism·2013
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026